000			01749 a2200517 4500
005			20250513062918.0
264		0	_c19940512
008			199405s 0 0 eng d
022			_a0305-7453
024	7		_a10.1093/jac/32.suppl_b.133 _2doi
040			_aNLM _beng _cNLM
100	1		_aMouton, Y
245	0	0	_aA non-comparative, multicentre study of cefepime in the treatment of serious bacterial infections. _h[electronic resource]
260			_bThe Journal of antimicrobial chemotherapy _cNov 1993
300			_a133-40 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aBacteria _xdrug effects
650	0	4	_aBacterial Infections _xdrug therapy
650	0	4	_aCefepime
650	0	4	_aCephalosporins _xadverse effects
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMicrobial Sensitivity Tests
650	0	4	_aMiddle Aged
650	0	4	_aRespiratory Tract Infections _xdrug therapy
650	0	4	_aRisk Factors
650	0	4	_aSepsis _xdrug therapy
650	0	4	_aSkin Diseases, Infectious _xdrug therapy
650	0	4	_aUrinary Tract Infections _xdrug therapy
700	1		_aChidiac, C
700	1		_aHumbert, G
700	1		_aLeroy, J
700	1		_aVeyssier, P
700	1		_aModai, J
700	1		_aBertrand, A
700	1		_aDellamonica, P
700	1		_aMicoud, M
700	1		_aStahl, J P
773	0		_tThe Journal of antimicrobial chemotherapy _gvol. 32 Suppl B _gp. 133-40
856	4	0	_uhttps://doi.org/10.1093/jac/32.suppl_b.133 _zAvailable from publisher's website
999			_c8150079 _d8150079